Citations

Showing 10 of 108094 citations.

Effects on physiologic measures of appetite from intragastric balloon and endoscopic sleeve gastroplasty: results of a prospective study
Rapaka, Babusai , Maselli, Daniel B. , López-Nava, Gontrand, Bautista-Castaño, Inmaculada , Jaruvongvanich, Veeravich , Matar, Reem , Vargas, Eric J. , Storm, Andrew C. , Acosta, Andrés , Dayyeh, Barham K. Abu

Mayo Clinic

Chinese Medical Journal | July 5, 2022 | Volume: 135 | Issue: 10 | Pages: 1234-1241

10.1097/cm9.0000000000002097 | PMID 35788090 Get It

Abstract Background: Endoscopic bariatric therapies can help address widening management gaps in obesity. Their ability to facilitate weight loss is largely tied to influences on appetite through perturbations of gastric emptying and accommodation. As these tools gain traction in obesity therapy, their physiologic underpinnings require exploration, which may enhance efficacy, tolerance, and patient-tailored care. Methods: We prospectively assessed consecutive subjects with fluid-filled intragastric balloons (IGBs) (n = 18) placed between October 2016 and June 2017 or underwent endoscopic sleeve gastroplasty (ESG) (n = 23) from March 2018 to June 2018. Patients underwent physiologic appraisal at 3 months with 13C-spirulina-based gastric emptying breath test to determine time to half emptying (T50), as well as maximum tolerated volume (MTV) of a standard nutrient drink test. Changes in T50 and MTV at 3 months were compared with percent total body weight loss (%TBWL) at 3 and 6 months using best-fit linear regression. Results: The change in T50 at 3 months correlated with %TBWL at 3 months for IGB (P = 0.01) and ESG (P = 0.01) but with greater impact on %TBWL in IGB compared to ESG (R 2 = 0.42 vs. 0.26). Change in T50 at 3 months was predictive of weight loss at 6 months for IGB (P = 0.01) but not ESG (P = 0.11). ESG was associated with greater decrease in MTV compared to IGB (340.25 ± 297.97 mL vs. 183.00 ± 217.13 mL, P = 0.08), indicting an enhanced effect on satiation through decreased gastric accommodation. Changes in MTV at 3 months did not correlate with %TBWL for either IGB (P = 0.26) or ESG (P = 0.49) but trended toward significance for predicting %TBWL at 6 months for ESG (P = 0.06) but not IGB (P = 0.19). Conclusion: IGB and ESG both induce weight loss but likely through distinct gastric motor function phenotypes, and gastric emptying may predict future weight loss in patients with IGB.
Stress Resilience Program for Health Care Professionals During a Pandemic: A Pilot Program
Croghan, Ivana T. , Fokken, Shawn C. , Lindeen, Stephanie A. , Schroeder, Darrell R. , Ghosh, Karthik, Bauer, Brent A. , Lindeen, Stephanie A , Schroeder, Darrell , Hurt, Ryan T. , Fischer, Karen M. , Ganesh, Ravindra , Bausek, Nina

Mayo Clinic

Workplace Health & Safety | July 5, 2022 | Volume: 71 | Issue: 4 | Pages: 173-180

10.1177/21650799221093775 | PMID 35787711 Get It

Background: The COVID-19 pandemic has led to increased burnout and staff turnover for health care providers (HCPs). The purpose of this pilot study was to evaluate the safety and acceptability of a Stress Resilience Program (SRP) for reducing perceived stress and improving resilience among HCPs during a pandemic. Method: Of the 12 HCPs expressing interest in the study, 10 were enrolled in this study. Participants attended three in-person visits (consent/screen, baseline, and end-of-study). The SRP consisted of education related to resilience enhancement and a breathing device ( BreatherFit®) for combined respiratory muscle training (cRMT). Participants completed 4 weeks of cRMT and applied situational breathing strategies as needed. Outcomes measured were changes in stress (PSS-10), resilience (BRS), depression (PRIME-MD), and sleep (PSQI and Ōura Ring®). Findings: The majority of participants were male (60%) and White (60%) with an average age of 39.7 years. Changes from baseline to end-of-treatment indicated a positive trend with significant stress reduction (−3.2 ± 3.9, p = .028) and nonsignificant depression reduction (−0.5 ± 0.7, p = .05). Resilience was high at baseline and continued to stay high during the study with a nonsignificant increase at end-of-study (+0.07 ± 0.7, p = .77). No changes in overall sleep scores were noted. All participants agreed the study was worthwhile, 80% indicated they would repeat the experience, while 90% indicated they would recommend the study to others. Conclusion/Application to Practice: Because of its size and portability, SRP is an easily applicable and promising option for reducing stress among HCPs during a high-stress period, such as a pandemic. Larger studies are needed.
Massive left atrial thrombus evades multimodality imaging as a myxoma in a bicaval heart transplant recipient
Shou, Benjamin L. , Halub, Meghan E, Zhou, Alice L. , Tompkins, Bryon A. , Choi, Chun Woo

Mayo Clinic

Journal of Cardiac Surgery | July 5, 2022 | Volume: 37 | Issue: 9 | Pages: 2884-2887

10.1111/jocs.16708 | PMID 35789119 Get It

Abstract Intracardiac masses are an extremely rare and poorly described complication following a bicaval heart transplantation. We describe the case of an asymptomatic 62‐year‐old male with a large left atrial mass found incidentally on transthoracic echocardiography 6 years post‐transplant. A battery of additional imaging tests was ordered including transesophageal echocardiography, 18 F‐fluorodeoxyglucose positron emission tomography/computed tomography, and T1 and T2 magnetic resonance imaging. Although imaging biomarkers were generally nonspecific, the mass was most consistent with a cardiac myxoma. However, intraoperative findings confirmed by pathology revealed a massive organizing thrombus. The patient had an uneventful recovery after surgical removal of the mass. Our case highlights a very rare phenomenon in heart transplant recipients which remains a unique diagnostic challenge even with current advances in imaging.
Quantifying Individual-Level Inaccuracy in Glomerular Filtration Rate Estimation
Shafi, Tariq , Zhu, Xiaoqian , Lirette, Seth T. , Rule, Andrew D. , Butler, Kenneth R. , Hall, Michael E. , Vaitla, Pradeep , Wynn, J. D. , Tio, Maria Clarissa , Butler, Javed , Butler, Kenneth R , Vaitla, Pradeep K , Wynn, James J , Guallar, Eliseo , Rule, Andrew D , Lirette, Seth , Shafi, Tariq , Mosley, Thomas H. , Dossabhoy, Neville R. , Güallar, Eliseo

Mayo Clinic

Annals of Internal Medicine | July 4, 2022 | Volume: 175 | Issue: 8 | Pages: 1073-1082

10.7326/m22-0610 | PMID 35785532 Get It

In critically ill patients with COVID-19, antiplatelet therapy did not increase organ support–free days at 21 d
Athale, Janhavi, Danner, Robert L.

Mayo Clinic

Annals of Internal Medicine | July 4, 2022 | Volume: 175 | Issue: 7 | Pages: JC80

10.7326/j22-0046 | PMID 35785539 Get It

Toward Robust Stress Prediction in the Age of Wearables: Modeling Perceived Stress in a Longitudinal Study With Information Workers
Booth, Brandon M. , Vrzáková, Hana , Martinez, Gonzalo J. , Faust, Louis , D’Mello, Sidney K. , Mattingly, Stephen M.

Mayo Clinic

IEEE Transactions on Affective Computing | July 4, 2022 | Volume: 13 | Issue: 4 | Pages: 2201-2217

10.1109/taffc.2022.3188006 Get It

Comment on: Survival and associated comorbidities in inclusion body myositis: Reply
Naddaf, Elie , Naddaf, Elie

Mayo Clinic

Rheumatology | July 4, 2022 | Volume: 61 | Issue: 11 | Pages: e348-e349

10.1093/rheumatology/keac379 | PMID 35781321 Get It

The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex – a multicenter-study of 3566 Caucasian and Asian subjects
Spyroglou, Ariadni , Handgriff, Laura, Schwarzlmueller, Paul , Parasiliti‐Caprino, Mirko , Fuß, Carmina Teresa , Remde, Hana, O’Toole, Samuel , Thuzar, Moe , Deflorenne, Elisa, Vrckovnik, Rok, Kocjan, Tomaž , Zhang, Catherine D , Li, Dingfeng , Singh, Sumitabh , Katabami, Takuyuki , Yoneda, Takashi , Murakami, Masanori , Wada, Norio , Maccario, Mauro , Drake, William M , Reincke, Martín , Beuschlein, Felix , Katabami, Takuyuki , Quinkler, Marcus , Fassnacht, Martin , Bancos, Irina , Reincke, Martin , Beuschlein, Felix , Kocjan, Tomaz , Parasiliti-Caprino, Mirko , Murakami, Masanori , Müller, Lisa , Hirsch, Anna K. H. , Petramala, Luigi , Letizia, Claudio , Amar, Laurence , Inagaki, Nobuya , Quinkler, Marcus , Ghigo, Ezio , Stowasser, Michael , Faßnacht, Martin , Bancos, Irina , Naruse, Mitsuhide

Mayo Clinic

European Journal of Endocrinology | July 4, 2022 | Volume: 187 | Issue: 3 | Pages: 361-372

10.1530/eje-22-0040 | PMID 35895721 Get It

Background Accumulating evidence suggests that primary aldosteronism (PA) is associated with several features of the metabolic syndrome, in particular with obesity, type 2 diabetes mellitus, and dyslipidemia. Whether these manifestations are primarily linked to aldosterone-producing adenoma (APA) or bilateral idiopathic hyperaldosteronism (IHA) remains unclear. The aim of the present study was to investigate differences in metabolic parameters between APA and IHA patients and to assess the impact of treatment on these clinical characteristics. Methods We conducted a retrospective multicenter study including 3566 patients with APA or IHA of Caucasian and Asian origin. We compared the prevalence of metabolic disorders between APA and IHA patients at the time of diagnosis and 1-year post-intervention, with special references to sex differences. Furthermore, correlations between metabolic parameters and plasma aldosterone, renin, or plasma cortisol levels after 1 mg dexamethasone (DST) were performed. Results As expected, APA patients were characterized by higher plasma aldosterone and lower serum potassium levels. Only female IHA patients demonstrated significantly worse metabolic parameters than age-matched female APA patients, which were associated with lower cortisol levels upon DST. One-year post-intervention, female adrenalectomized patients showed deterioration of their lipid profile, when compared to patients treated with mineralocorticoid receptor antagonists. Plasma aldosterone levels negatively correlated with the BMI only in APA patients. Conclusions Metabolic alterations appear more prominent in women with IHA. Although IHA patients have worse metabolic profiles, a correlation with cortisol autonomy is documented only in APAs, suggesting an uncoupling of cortisol action from metabolic traits in IHA patients.
Therapeutic Interventions and Outcomes in Civilian and Military Isolated Gunshot Wounds to the Head
Δημητριάδης, Δημήτριος , Owattanapanich, Natthida , Shackelford, Stacy , Roedel, Erik, Polk, Travis M. , Biswas, Subarna , Rasmussen, Todd, Benjamin, Elizabeth , Rasmussen, Todd E.

Mayo Clinic

Annals of Surgery | July 4, 2022 | Volume: 278 | Issue: 1 | Pages: e131-e136

10.1097/sla.0000000000005496 | PMID 35786669 Get It

Objective: The purpose of this study was to compare therapeutic strategies and outcomes, following isolated gunshot wounds of the head, between military and civilian populations. Background: Recent military conflicts introduced new concepts in trauma care, including aggressive surgical intervention in severe head trauma. Methods: This was a cohort-matched study, using the civilian Trauma Quality Improvement Program (TQIP) database of the American College of Surgeons (ACS) and the Department of Defense Trauma Registry (DoDTR), during the period 2013 to 2016. Included in the study were patients with isolated gunshots to the head. Exclusion criteria were dead on arrival, civilians transferred from other hospitals, and patients with major extracranial associated injuries (body area Abbreviated Injury Scale >3). Patients in the military database were propensity score–matched 1:3 with patients in the civilian database. Results: A total of 136 patients in the DoDTR database were matched for age, sex, year of injury, and head Abbreviated Injury Scale with 408 patients from TQIP. Utilization of blood products was significantly higher in the military population (P<0.001). In the military group, patients were significantly more likely to have intracranial pressure monitoring (17% vs 6%, P<0.001) and more likely to undergo craniotomy or craniectomy (34% vs 13%, P<0.001) than in the civilian group. Mortality in the military population was significantly lower (27% vs 38%, P=0.013). Conclusions: Military patients are more likely to receive blood products, have intracranial pressure monitoring and undergo craniectomy or craniotomy than their civilian counterparts after isolated head gunshot wounds. Mortality is significantly lower in the military population. Level of Evidence: Level III—therapeutic.
SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes
Pawlowski, Colin , Silvert, Eli , O’Horo, John C. , Lenehan, Patrick J. , Gnass, Esteban , Ross, Jason , Speicher, Leigh L. , Geyer, Holly L. , Venkatakrishnan, A J, Challener, Douglas , Ross, Jason , Speicher, Leigh, Geyer, Holly, Soundararajan, Venky , O'Horo, John C , Lenehan, Patrick J , Challener, Douglas W. , Murugadoss, Karthik , Venkatakrishnan, A J , Badley, Andrew D. , Soundararajan, Venky

Mayo Clinic

PNAS Nexus | July 4, 2022 | Volume: 1 | Issue: 3 | Pages: No page available

10.1093/pnasnexus/pgac071 | PMID 35860600 Get It

Abstract Case reports of patients infected with COVID-19 and influenza virus (“flurona”) have raised questions around the prevalence and severity of coinfection. Using data from HHS Protect Public Data Hub, NCBI Virus, and CDC FluView, we analyzed trends in SARS-CoV-2 and influenza hospitalized coinfection cases and strain prevalences. We also characterized coinfection cases across the Mayo Clinic Enterprise from January 2020 to April 2022. We compared expected and observed coinfection case counts across different waves of the pandemic and assessed symptoms and outcomes of coinfection and COVID-19 monoinfection cases after propensity score matching on clinically relevant baseline characteristics. From both the Mayo Clinic and nationwide datasets, the observed coinfection rate for SARS-CoV-2 and influenza has been higher during the Omicron era (2021 December 14 to 2022 April 2) compared to previous waves, but no higher than expected assuming infection rates are independent. At the Mayo Clinic, only 120 coinfection cases were observed among 197,364 SARS-CoV-2 cases. Coinfected patients were relatively young (mean age: 26.7 years) and had fewer serious comorbidities compared to monoinfected patients. While there were no significant differences in 30-day hospitalization, ICU admission, or mortality rates between coinfected and matched COVID-19 monoinfection cases, coinfection cases reported higher rates of symptoms including congestion, cough, fever/chills, headache, myalgia/arthralgia, pharyngitis, and rhinitis. While most coinfection cases observed at the Mayo Clinic occurred among relatively healthy individuals, further observation is needed to assess outcomes among subpopulations with risk factors for severe COVID-19 such as older age, obesity, and immunocompromised status.